| Company |
Novartis |
| Affiliations |
Massachusetts College of Pharmacy and Health Science |
| Fellowship director |
- Biomarker Development: Dr. Dmitri Mikhailov
- Clinical Operations – General Medicine: Megan Osborn, BS
- Clinical Operations – Translational Clinical Oncology: Dr Craig Talluto
- Regulatory Affairs: Dr. Monica Pham & Dr. Emily Harris
|
| Email |
pharmd.fellowships@novartis.com |
| Website |
https://www.mcphs.edu/academics/postgraduate-opportunities/biopharmaceutical-fellowships/novartis-fellowships |
| Brochure URL |
https://issuu.com/mcphspublications/docs/mcphs_novartis_fellowships?e=4702537/58766916 |
|
| Position(s) |
|
| Position |
Biomarker Development (1 position) |
| Program length |
2 years |
| Application due date |
- CV: November 11, 2022
- LOI: November 11, 2022
- LOR: December 1, 2022
|
| Location |
Cambridge, MA |
|
| Position |
Clinical Operations - General Medicine (1 position) |
| Program length |
2 years |
| Application due date |
- CV: November 11, 2022
- LOI: November 11, 2022
- LOR: December 1, 2022
|
| Location |
Cambridge, MA |
|
| Position |
Clinical Operations - Translational Clinical Oncology (1 position) |
| Program length |
2 years |
| Application due date |
- CV: November 11, 2022
- LOI: November 11, 2022
- LOR: December 1, 2022
|
| Location |
Cambridge, MA |
|
| Position |
Regulatory Affairs (1 position) |
| Program length |
2 years |
| Application due date |
- CV: November 11, 2022
- LOI: November 11, 2022
- LOR: December 1, 2022
|
| Location |
Cambridge, MA |
